Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients

Journal of Clinical Investigation

Volumn 99, Issue 1, 1997, Pages 97-105

  Garibotto, Giacomo ^a   Barreca, Antonina ^b   Russo, Rodolfo ^a   Sofia, Antonella ^a   Araghi, Paolo ^a   Cesarone, Arianna ^b   Malaspina, Mauro ^c   Fiorini, Fulvio ^d   Minuto, Francesco ^b   Tizianello, Alberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Sampierdarena   (Italy)

^d Bussana Hospitals   (Italy)

Author keywords

growth hormone; hemodialysis; malnutrition; potassium; protein synthesis

Indexed keywords

HUMAN GROWTH HORMONE; MUSCLE PROTEIN; PHENYLALANINE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; CATABOLISM; CLINICAL ARTICLE; GROWTH HORMONE BLOOD LEVEL; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; MALNUTRITION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS;

EID: 0031036914     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119139     Document Type: Article

References (59)

1. Bergstrom, J. 1996. Nutrition and mortality in hemodialysis. J. Am. Soc. Nephrol. 6:1329-1341.
2. Reaich, D., S.R. Price, B.K. England, and W.E. Mitch. 1995. Mechanisms causing muscle loss in chronic renal failure. Am. J. Kidney Dis. 26:242-247.
3. Price, S.R., B.K. England, J.L. Bailey, K. Van Vreede, and W.E. Mitch. 1994. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am. J. Physiol. 267:C955-C960.
4. Garibotto, G., R. Russo, A. Sofia, M.R. Sala, C. Robaudo, P. Moscatelli, G. Deferrari, and A. Tizianello. 1994. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int. 45:1432-1439.
5. Lim, V.S., D.M. Bier, M.J. Flanigan, and S.T. Sum-Ping. 1993. The effect of hemodialysis on protein metabolism. A leucine kinetic study. J. Clin. Invest. 91:2429-2436.
6. Chan, W., C.V. Kristoffer, and J.C.M. Chan. 1993. Expression of insulin-like growth factor-1 in uremic rats: Growth hormone resistance and nutritional intake. Kidney Int. 43:790-795.
7. Tonshoff, B., S. Edén, E. Weiser, B. Carlsson, I.C.A.F. Robinson, W. Blum, and O. Mehls. 1994. Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int. 45:1085-1092.
8. Kopple, J.D., H. Ding, and X.L. Gao. 1995. Altered physiology and action of insulin-like growth factor-1 in skeletal muscle in chronic renal failure. Am. J. Kidney Dis. 26:248-255.
9. Ding, H., X.L. Gao, R. Hirschberg, J.V. Vadgama, and J.D. Kopple. 1996. Impaired actions of Insulin-like Growth Factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. J. Clin. Invest. 97:1064-1075.
10. Haffner, D., F. Schaefer, J. Girard, E. Ritz, and O. Mehls. 1994. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J. Clin. Invest. 93:1163-1171.
11. Krieg, R.J., F. Santos, and J.C.M. Chan. 1995. Growth hormone, insulin like growth factor and the kidney. Kidney Int. 48:321-326.
12. Fouque, D., S. Peng, and J.D. Kopple. 1995. Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients. Kidney Int. 47:851-857.
13. Phillips, L.S., A.C. Fusco, T.G. Unterman, and F. Del Greco. 1994. Somatomedin inhibitor in uremia J. Clin. Endocrinol. Metab. 59:764-772.
14. Thyssen, P., J.M. Ketelslegers, and L.E. Underwood. 1994. Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 15:80-101.
15. Manson, J.M., and D.W. Wilmore. 1986. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery (St. Louis). 100:188-197.
16. Salomon, F., R.C. Cuneo, R. Hesp, and Sonksen P.H.. 1989. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321: 1797-1803.
17. Forbes, G.B. 1988. Body composition: influence of nutrition, disease, growth and aging. In Modern Nutrition in Health and Disease. M.E. Shils and V.R. Young, editors. 7th ed. Lea and Febiger, Philadelphia. 533-556.
18. Fine, R.N., K. Pyke-Grimm, and P.A. Nelson. 1991. Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1 to 3 year) outcome. Pediatr. Nephrol. 5:477-481.
19. Ziegler, T.R., J.M. Lazarus, L.S. Young, R. Hakim, and D.W. Wilmore. 1991. Effects of recombinant growth hormone in adults receiving maintenance hemodialysis. J. Am. Soc. Nephrol. 2:1130-1135.
20. Schulman, G., R.L. Wingard, R.L. Hutchinson, P. Lawrence, and R.M. Hakim. 1993. The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am. J. Kidney Dis. 21:527-534.
21. Kopple, J.D. 1992. The rationale for the use of growth hormone or insulin-like growth factor-I in adult patients with renal failure. Miner. Electrolyte Metab. 18:269-275.
22. Ikizler, T.A., R. Wingard, J. Breyer, G. Schulman, R. Parker, and R. Hakim. 1994. Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Intern. 46:1178-1183.
23. Gelfand, R.A., and E.J. Barrett. 1987. Effect of physiological hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J. Clin. Invest. 80:1-6.
24. Metropolitan Life Foundation. 1983. Metropolitan height and weight tables. Stat. Bull. Metrop. Life Insur. Co. 64:2-17.
25. Borah, M.F., P.Y. Schoenfeld, F.A. Gotch, J.A. Sargent, M. Wolfson, and M.H. Humphreys. 1978. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int. 14:491-500.
26. Tizianello, A., G. Deferrari, G. Gurreri, G. Garibotto, and C. Robaudo. 1980. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J. Clin. Invent. 65: 1163-1173.
27. Doughaday, W.H., I.K. Martz, and S.L. Blethen. 1980. Inhibition of access of bound somatomedin to membrane receptor and immunoglobulin sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J. Clin. Endocrinol. Metab. 19:781-788.
28. Garibotto, G., G. Deferrari, C. Robaudo, S. Saffioti, M.R. Sala, E. Paoletti, and A. Tizianello. 1991. Effects of a new amino acid supplement on blood amino acid pools in patients with chronic renal failure. Amino Acids (Vienna). 1:319-329.
29. Garibotto, G., R. Russo, A. Sofia, C. Robaudo, P. Araghi, G. Deferrari, and A. Tizianello. 1995. Protein intake and muscle protein turnover in chronic renal failure patients. J. Am. Soc. Nephrol. 6:388. (Abstr).
30. Louard, R.J., D.A. Fryburg, R.A. Gelfand, and E.J. Barret. 1992. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. J. Clin. Invest. 90:2348-2354.
31. Guarnieri G., G. Toigo, R. Situlin, L. Faccini, U. Colli, S. Landini, G. Bazzato, F. Dardi, and L. Campanacci. 1983. Muscle biopsy studies in chronically uremic patients: Evidence for malnutrition. Kidney Int. 24 (Suppl. 16): S187-S193.
32. Horber, F.F., and M.W. Haymond. 1990. Human growth hormone prevents the catabolic side effects of prednisone in humans. J. Clin. Invest. 86:265-272.
33. Fryburg, D.A., and E.J. Barret. 1993. Growth hormone acutely stimulates skeletal muscle but not whole body protein synthesis in humans. Metab. Clin. Exp. 42:1223-1227.
34. Fryburg, D.A., R.A. Gelfand, and E.J. Barrett. 1991. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am. J. Physiol. 260 (Endocrinol. Metab. 23):E499-E504.
35. Fryburg, D.A., R. Louard, K. Gerow, R. Gelfand, and E. Barret. 1992. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes. 41:424-429.
36. Copeland, K.C., and K.S. Nair. 1994. Acute growth hormone effects on amino acid and lipid metabolism. J. Clin. Endocrinol. Metab. 78:1040-1047.
37. Laager, R., R. Ninnis, and U. Keller. 1993. Comparison of the effects of recombinant human insulin-like growth factor-1 and insulin on glucose and leucine kinetics in humans. J. Clin. Invest. 92:1903-1909.
38. Mauras, N., and B. Beaufrère. 1995. Recombinant human insulin-like factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect. J. Clin. Endocrinol. Metab. 80:869-874.
39. Fryburg, D.A. 1994. Insulin-like growth factor-1 exerts growth hormone-and insulin-like actions on human muscle protein metabolism. Am. J. Physiol. 267:E331-E336.
40. Lee, P.D.K., C.A. Conover, and D.R. Powell. 1993. Regulation and function of insulin-like growth factor-binding protein-1. Proc. Soc. Exp. Biol. Med. 204:4-29.
41. Hokken-Koelega, A.C.S., T. Stijnene, S.M.P.F. de Muinck Kaizer-Schrama, J.M. Wit, E.D. Wolff, M.C.J.W. De Jong, R.A. Donckerwolcke, N.C.B. Abbad, A. Bot, W.F. Blum, et al. 1991. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepurbertal children with chronic renal failure. Lancet. 338:585-590.
42. Brismar, K., E. Fernqvist-Forbes, J. Wahren, and K. Hall. 1994. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 79:872-878.
43. Welbourne, T., S. Joshi, and R. McVie. 1989. Growth hormone effects on hepatic glutamate handling in vivo. Am. J. Physiol. 257:E959-E962.
44. Tizianello, A., G. Deferrari, G. Garibotto, C. Robaudo, S. Saffioti, and E. Paoletti, 1988. Abnormalities of amino acid and keto acid metabolism in chronic renal failure. In Nephrology. A.M. Davison, editor. Baillère-Tindall, London. 1011-1025.
45. Deferrari, G., G. Garibotto, C. Robaudo, A. Canepa, S. Bagnasco and A. Tizianello. 1985. Leg metabolism of amino acids and ammonia in patients with chronic renal failure. Clin. Sci. (Lond.). 69:143-151.
46. Anders, R., M.A. Baltzan, G. Cader, and K. Zierler. 1962. Effect of insulin on carbohydrate metabolism and on potassium in the forearm of man. J. Clin. Invest. 41:108-115.
47. Allon, M. 1995. Hyperkalemia in end-stage renal disease: mechanisms and management. J. Am. Soc. Nephrol. 6:1134-1142.
48. Goecke, I.A., S. Bonilla, E.T. Marusic, and M. Alvo. 1991. Enhanced insulin sensitivity in extrarenal potassium handling in uremic rats. Kidney Intern. 39:39-43.
49. Bonilla, S., I.A. Goecke, S. Bozzo, M. Alvo, L. Michea, and E.T. Marusic. 1991. Effect of chronic renal failure on NA-K ATP-ase alpha-1 and alpha-2 mRNA transcription in rat skeletal muscle. J. Clin. Invest. 88:2137-2141.
50. Allon, M., A. Takeshian, N. Shanklin. 1993. Effect of insulin plus glucose infusion with or without epinephrine on fasting hyperkaliemia. Kidney Intern. 43:212-217.
51. Allon, M., L. Dansby, and N. Shanklin. 1993. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease. Am. J. Med. 94:475-482.
52. Perrone, R.D., and E.A. Alexander. 1994. Regulation of extrarenal potassium metabolism. In Maxwell and Kleeman's Clinical Disorders of Fluid and Electrolyte Metabolism. R.G. Narins, editor. Mac Graw-Hill Inc., New York. 129-145.
53. Zierler, K.L., and D. Rabinovitz. 1963. Roles of insulin and growth hormone, based on studies of forearm metabolism in man. Medicine (Baltimore). 42:385-401.
54. Valk, N.K., A.J. Lely, W.W. De Herder, J. Lindemans, and S.W.J. Lamberts. 1994. The effects of human growth hormone administration in GH-deficient adults: a 20-day metabolic ward study J. Clin. Endocrinol. Metab. 79:1070-1076.
55. Cannon, P., L.E. Frazier, and R. Hughes. 1951. Influence of potassium on tissue protein synthesis. Metab. Clin. Exp. 1:49-57.
56. Alexis, S.D., G. Vilaire, and V. Young. 1971. Cell-free studies of protein synthesis with skeletal muscle from normal and potassium-depleted rats. J. Nutr. 101:273-286.
57. Adrogué, H.J. 1991. Mechanims of transcellular potassium shifts in acidbase disorders. In Nephrology. Proc. XIIth Congr. Intern. Soc. Nephrol. M. Hatano, editor Springer-Verlag New York Inc., New York. 252-261.
58. Yki-Jarvinen, H., A. Young, C. Lamkin, and J. Foley. 1987. Kinetics of glucose disposal in whole body and across the forearm in man. J. Clin. Invest. 79:1713-1719.
59. Clowes, G.H.A., H.T. Randall Jr., and J.C. Chan. 1980. Amino acid and energy metabolism in septic and traumatized patients. J. Parenter. Enteral. Nutr. 4:195-205.